Dr. Prat is a clinical scientist with expertise in breast cancer research, clinical trials, and gene expression. He has a MD degree from the University of Barcelona and completed a medical oncology fellowship at the Vall d'Hebron Institute of Oncology. He is Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute, President of the Board of Directors of SOLTI, and member of the Executive Committee of The Breast International Group. He has published 160 publications with 13.479 citations and is a Tenure-Track Professor of Barcelona University and Director of the Breast Pathology – Senology Master´s degree.
Read moreDr. Prat is a clinical scientist with expertise in breast cancer research, clinical trials, and gene expression. He has a MD degree from the University of Barcelona and completed a medical oncology fellowship at the Vall d'Hebron Institute of Oncology. He is Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute, President of the Board of Directors of SOLTI, and member of the Executive Committee of The Breast International Group. He has published 160 publications with 13.479 citations and is a Tenure-Track Professor of Barcelona University and Director of the Breast Pathology – Senology Master´s degree.
Dr. Joan Albanell Mestres is a highly experienced oncologist with an extensive educational and research background. He has completed his MBBS from University Autónoma de Barcelona and has led various research and oncology programs. He has published 120 articles in reputable journals with more than 9000 citations.
Read moreDr. Joan Albanell Mestres is a highly experienced oncologist with an extensive educational and research background. He has completed his MBBS from University Autónoma de Barcelona and has led various research and oncology programs. He has published 120 articles in reputable journals with more than 9000 citations.